AI discovers antibiotic to treat drug-resistant diseases for first time
Researchers used computer model that can screen more than a hundred million chemical compounds in a matter of days
Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.Scientists have used artificial intelligence to uncover new types of antibiotics in the face of growing concerns about resistance to the drugs.
A group of researchers from Massachusetts Institute of Technology (MIT) say their machine-learning algorithm was able to identify a powerful new antibiotic compound, capable of killing some of the world’s most problematic disease-causing bacteria.
They claim the technology is able to work more quickly and efficiently than existing systems, because it checks more than a hundred million chemical compounds in a matter of days to pick out potential antibiotics that kill bacteria.
The AI was trained specifically to track down possible antibiotic molecules known for being effective against E.coli growth.
“We’re facing a growing crisis around antibiotic resistance, and this situation is being generated by both an increasing number of pathogens becoming resistant to existing antibiotics, and an anaemic pipeline in the biotech and pharmaceutical industries for new antibiotics,” said MIT’s Professor James Collins, who is also co-founder of an antibiotic drug discovery firm EnBiotix.
“We wanted to develop a platform that would allow us to harness the power of artificial intelligence to usher in a new age of antibiotic drug discovery.
“Our approach revealed this amazing molecule which is arguably one of the more powerful antibiotics that has been discovered.”
The molecule, named halicin, proved effective against E.coli, which did not develop any resistance to it during a 30-day treatment period on mice.
Researchers, who published their paper in the Cell journal, say they want to study halicin further in hope of developing it for use in humans.
Press Association
Subscribe to Independent Premium to bookmark this article
Want to bookmark your favourite articles and stories to read or reference later? Start your Independent Premium subscription today.
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies
Comments